Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
CNY 75.33
(-0.49%)
CNY 75.33
(-0.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.47 Billion | 11.18 Billion | 5.75 Billion | 2.35 Billion | 1.18 Billion | 982.68 Million |
| Cost of Revenue | 978.7 Million | 1.17 Billion | 817.71 Million | 442.14 Million | 330.86 Million | 269.08 Million |
| Gross Profit | 4.49 Billion | 10.01 Billion | 4.93 Billion | 1.91 Billion | 852.88 Million | 713.6 Million |
| Operating Expenses | 3.13 Billion | 4.41 Billion | 2.49 Billion | 1.08 Billion | 631.59 Million | 541.7 Million |
| Selling, General and Administrative Expenses | 1.83 Billion | 3.29 Billion | 1.72 Billion | 714.88 Million | 356.87 Million | 293.58 Million |
| Research and Development Expenses | 1.19 Billion | 1.09 Billion | 681.82 Million | 314.33 Million | 165.97 Million | 138.33 Million |
| Other Expenses | -27.08 Million | 19.63 Million | 86.42 Million | 57.16 Million | 108.73 Million | 1.16 Million |
| Cost and Expenses | 4.1 Billion | 5.58 Billion | 3.31 Billion | 1.52 Billion | 962.46 Million | 810.78 Million |
| Operating Income | 1.4 Billion | 5.59 Billion | 2.32 Billion | 775.2 Million | 218.33 Million | 289.12 Million |
| Interest Expense | 6.86 Million | 7.66 Million | 5.69 Million | 1.68 Million | 1.04 Million | 6.03 Million |
| Income Tax Expense | 146.88 Million | 719.38 Million | 244.93 Million | 82.63 Million | 6.5 Million | -2.58 Million |
| Earnings before Tax | 1.39 Billion | 5.58 Billion | 2.32 Billion | 764.45 Million | 216.8 Million | 290.28 Million |
| Net Income | 1.24 Billion | 4.73 Billion | 2.02 Billion | 676.99 Million | 208.86 Million | 293.06 Million |
| Earnings Per Share Basic | 0.99 | 3.79 | 1.64 | 0.55 | 0.17 | 0.27 |
| Earnings Per Share Diluted | 0.99 | 3.79 | 1.64 | 0.55 | 0.17 | 0.27 |
| Weighted Average Shares Outstanding | 1.26 Billion | 1.24 Billion | 1.23 Billion | 1.23 Billion | 1.23 Billion | 1.06 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.26 Billion | 1.24 Billion | 1.23 Billion | 1.23 Billion | 1.23 Billion | 1.06 Billion |
| Gross Margin | 0.82 | 0.90 | 0.86 | 0.81 | 0.72 | 0.73 |
| EBIT Margin | 0.30 | 0.52 | 0.44 | 0.38 | 0.27 | 0.26 |
| Profit Margin | 0.23 | 0.42 | 0.35 | 0.29 | 0.18 | 0.30 |
| EBITDA | 1.65 Billion | 5.74 Billion | 2.43 Billion | 850.6 Million | 293.54 Million | 357.44 Million |
| Earnings Before Tax Margin | 0.26 | 0.50 | 0.40 | 0.33 | 0.18 | 0.29 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 582.06 Million | 604.96 Million | 749.56 Million | 5.47 Billion | 533.79 Million | 805.25 Million |
| Cost of Revenue | 182.3 Million | 217.72 Million | 202.77 Million | 978.7 Million | 257.02 Million | 185.6 Million |
| Gross Profit | 399.76 Million | 387.23 Million | 546.78 Million | 4.49 Billion | 276.76 Million | 619.65 Million |
| Operating Expenses | 459.34 Million | 415.13 Million | 529.43 Million | 3.13 Billion | 954.51 Million | 647.2 Million |
| Selling, General and Administrative Expenses | 368.32 Million | 162.14 Million | 313.53 Million | - | 165.1 Million | 412.47 Million |
| Research and Development Expenses | 246.28 Million | 245.09 Million | 206.73 Million | - | 385.25 Million | 349.24 Million |
| Other Expenses | -155.26 Million | -7.89 Million | -9.15 Million | -200.29 Million | -404.15 Million | -750.99 Thousand |
| Cost and Expenses | 641.64 Million | 632.86 Million | 732.2 Million | 4.11 Billion | 1.21 Billion | 832.8 Million |
| Operating Income | -8.1 Million | -27.89 Million | 17.35 Million | 1.36 Billion | -677.74 Million | 68.85 Million |
| Interest Expense | 1.15 Million | 1.48 Million | 1.72 Million | 6.86 Million | 961.08 Thousand | 1.98 Million |
| Income Tax Expense | -18.88 Million | -1.3 Million | -4.14 Million | 146.88 Million | -44.11 Million | -34.32 Million |
| Earnings before Tax | -11.99 Million | 132.5 Million | 125.63 Million | 1.39 Billion | -609.37 Million | 68.1 Million |
| Net Income | 6.16 Million | 134.77 Million | 125.7 Million | 1.24 Billion | -560.68 Million | 106 Million |
| Earnings Per Share Basic | 0.00 | 0.11 | 0.10 | - | -0.44 | 0.08 |
| Earnings Per Share Diluted | 0.00 | 0.11 | 0.10 | - | -0.44 | 0.08 |
| Weighted Average Shares Outstanding | 1.26 Billion | 1.21 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.26 Billion | 1.21 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion | 1.26 Billion |
| Gross Margin | 0.69 | 0.64 | 0.73 | 0.82 | 0.52 | 0.77 |
| EBIT Margin | -0.02 | 0.07 | 0.22 | - | -1.12 | 0.04 |
| Profit Margin | 0.01 | 0.22 | 0.17 | 0.23 | -1.05 | 0.13 |
| EBITDA | -10.83 Million | 42.69 Million | 167.56 Million | - | -599.77 Million | 35.97 Million |
| Earnings Before Tax Margin | -0.01 | -0.05 | 0.02 | 0.25 | -1.27 | 0.09 |
PNE3
TRIS
TPE
ETLN
CMBN
IJ8